NRX PHARMACEUTICALS
NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics for the treatment of central nervous system disorders and pulmonary diseases. It addresses life-threatening diseases that often go untreated by researching, developing, and scaling solutions to help people who most desperately need them. The company has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure, and is also developing NRX-100/101 which is the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. In July 2021, the Government of Israel awarded NRx the exclusive worldwide right to develop and market the BriLifeR COVID vaccine developed by the Israel Institute for Biological Research.
NRX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.nrxpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 484.254.6134
Email Addresses:
[email protected]
Total Funding:
80.8 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Microsoft Azure DNS GoDaddy DNS GoDaddy Email Fastly Hosted Fastly Load Balancer SMTP.com
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Curidium Medica
Curidium Medica identifies medicines and companion diagnostics for the treatment of central nervous system disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kinled Holding
Kinled Holding investment in Series C - NRx Pharmaceuticals
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.nrxpharma.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.06 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NRx Pharmaceuticals"
Our Company - NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of central nervous system disorders, specifically suicidal depression, and post …See details»
Leadership Team Archives - NRx Pharmaceuticals
He subsequently served as Senior Medical Director for Global Product Development at PPD, a global contract research organization. He is a graduate of the Massachusetts Institute of …See details»
NRx Pharmaceuticals, Inc. | LinkedIn
NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients and bring improved health to patients.See details»
NRx Pharmaceuticals, Inc. (NRXP)
See the company profile for NRx Pharmaceuticals, Inc. (NRXP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
NRx Pharmaceuticals - Crunchbase Company Profile
NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics for the treatment of central nervous system disorders and pulmonary diseases.See details»
NRx Pharmaceuticals, Inc. (NRXPW) Company Profile & Overview
Mar 4, 2025 NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal …See details»
NRx Pharmaceuticals
Apr 21, 2025 https://www.nrxpharma.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a …See details»
NRX Pharmaceuticals - Overview, News & Similar companies
Aug 21, 2024 Explore Complete Organization Structure. Is NRX Pharmaceuticals your ideal customer? Let us give you the heads up on whether it's a good time to reach out ... (484) 254 …See details»
NRx Pharmaceuticals, Inc. | Independent Equity …
Dec 1, 2023 Crystal Research Associates offers investor research & communications to boost visibility of promising companies, enhancing potential. Phone: (212) 851-6685See details»
NRx Pharmaceuticals, Inc. (NRXP) - Yahoo Finance Canada
See the company profile for NRx Pharmaceuticals, Inc. (NRXP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Who Owns NRx Pharmaceuticals – CanvasBusinessModel.com
Dec 19, 2024 Website: https://www.nrxpharma.com; Focus: Development of therapeutics for central nervous system disorders; Kickstart Your Idea with Business Model Canvas Template …See details»
Contact Us - NRx Pharmaceuticals
Cookie Duration Description; _wpfuuid: 11 years: This cookie is used by the WPForms WordPress plugin. The cookie is used to allows the paid version of the plugin to connect entries by the …See details»
NRx Pharmaceuticals (NRXP) Company Profile & Description
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal …See details»
NRx Pharmaceuticals (NRXP) Stock Price & Overview
2 days ago Website https://www.nrxpharma.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 4 analysts, the average rating for NRXP …See details»
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth …
Mar 12, 2025 - Conference call to take place at 8:30am ET-. WILMINGTON, Del., March 12, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", …See details»
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter …
10 hours ago NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced financial results …See details»
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter …
3 days ago Matthew Duffy Co-CEO, Hope Therapeutics, Inc. Chief Business Officer, NRx Pharmaceuticals, Inc. [email protected] Brian Korb Managing Partner, astr …See details»
NRx Pharmaceuticals Initiates Senior Level Finance and Business ...
Nov 5, 2021 NRx has agreed to a tech transfer and scale-up contract with an advanced viral vector, contract research, and manufacturing organization in the Luxembourg region, with the …See details»
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter …
10 hours ago "NRx's 2024 momentum has continued into 2025, as we have advanced regulatory filings for NRX-100 and NRX-101 and advanced the Company's commercial opportunity with …See details»
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter …
10 hours ago NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for …See details»